Is TB-500 Legal in South Carolina? How to Access It Legally
HealthRX.com
No list shows this peptide can be compounded in South Carolina
See the public record for TB-500
At a glance
- Drug / TB-500, a synthetic 7-amino-acid fragment of thymosin beta-4 [1]
- FDA approval / None [1]
- List for state-licensed pharmacies and physicians / Not listed [2][4]
- List for outsourcing facilities / Not listed [3]
- HHS draft policy / Enforcement discretion for TB-500 acetate by injection if conditions are met; not binding, not an approval [6][7]
- Sport / Prohibited at all times by WADA [8][9]
What TB-500 is, and is it approved?
TB-500 is a synthetic, N-acetylated 7-amino-acid fragment of thymosin beta-4 - residues 17 to 23 of the 43-amino-acid protein - not the full protein [1]. It is not an FDA-approved drug: FDA's July 2026 review found no USP or National Formulary monograph, no FDA-approved drug containing it, and no approved product in Canada, Australia, the UK, Belgium, Ireland, France, Norway, Germany, Spain or Italy or authorized by the European Medicines Agency [1]. FDA found no published study in which a person received TB-500 [1].
Is it on FDA's compounding lists?
State-licensed pharmacies and physicians may only compound with bulk substances that meet a USP or National Formulary monograph, are components of an FDA-approved drug, or appear on FDA's bulks list [4]. FDA found none of the first two for TB-500, and it is not on the bulks list [1].
TB-500 appears in none of the three categories on FDA's list for state-licensed pharmacies and physicians [2][4] and is absent from the separate list for outsourcing facilities [3]. FDA's safety-risk page places 'Thymosin beta-4, fragment (LKKTETQ), also known as TB-500' in the table of substances nominated but withdrawn; removal from category 2 was not a finding that it is safe [10].
FDA reports that TB-500 is sold online as 'research use only' injectable powder, and that it found no pharmacy marketing a compounded TB-500 product and no outsourcing facility reporting one [1].
Questions worth asking
What changed in 2026
FDA's Pharmacy Compounding Advisory Committee voted on July 23, 2026 in favor of adding TB-500 to the list, against FDA staff's recommendation; that advice is non-binding, and adding a substance takes formal rulemaking [11][6].
HHS filed a draft enforcement-discretion policy naming TB-500 among six peptides [6][7]. It covers TB-500 acetate by subcutaneous or intramuscular injection and says HHS does not intend to take enforcement action against a state-licensed pharmacy, federal facility or licensed physician compounding with it when conditions are met, such as a single active ingredient, a patient-specific prescription and an FDA-registered manufacturer with a certificate of analysis [6][7]. The notice states it 'does not establish any rights for any person and is not binding on HHS or the public' [6].
What does the South Carolina Medical Board's page show?
The South Carolina Board of Medical Examiners licenses and disciplines physicians and lists a notice titled 'Notice Concerning the Prescribing of Research-Grade Peptides and FDA-Ineligible Peptides' [5]. The Board's page shows only that title, not what the notice requires for TB-500 [5]. Compounded drugs are not FDA-approved: FDA does not review their safety, effectiveness or quality before marketing [6].
Human data and sport
There is no approved dose and no human dosing study of TB-500 [1]. An FDA adverse-event database search through March 26, 2025 retrieved no TB-500 reports, and FDA found no published case reports, so safety in humans is unknown [1]. WADA names 'Thymosin-beta4 and its derivatives e.g. TB-500' in S2.3 and prohibits it at all times, on both the 2026 and 2027 Lists [8][9].
Check what you know
Question 1 of 4
Score: 0 right, 0 of 4 answered
Frequently asked questions
Is TB-500 legal in South Carolina?
What does the July 2026 advisory committee vote mean?
Is TB-500 the same as thymosin beta-4?
Is TB-500 banned in sport?
References
Show all 11 referencesHide references
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- Bulk Drug Substances Used in Compounding of the FD&C Act | FDA.
- SCLLR. SCLLR
- Official web page.
- Official web page.
- World Anti-Doping Agency.
- World Anti-Doping Agency.
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
- U.S. Food and Drug Administration.